Not yet recruitingPhase 2NCT07058025
Mesenchymal Stromal Cell Therapy to Prevent Bronchopulmonary Dysplasia in Extreme Preterm Infants
Studying Bronchopulmonary dysplasia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Ottawa Hospital Research Institute
- Principal Investigator
- Bernard Thébaud, MD, PhDOttawa Hospital Research Institute
- Intervention
- Human Allogenic Umbilical Cord Mesenchymal Stromal Cells(biological)
- Enrollment
- 168 enrolled
- Eligibility
- All sexes
- Timeline
- 2025 – 2038
Study locations (8)
- Royal Alexandra Hospital/Stollery Children's Hospital, Edmonton, Alberta, Canada
- McMaster Children's Hospital, Hamilton, Ontario, Canada
- The Ottawa Hospital, Ottawa, Ontario, Canada
- Sunnybrook Health Sciences Ctr, Toronto, Ontario, Canada
- Mount Sinai Hospital, Toronto, Ontario, Canada
- CHU Sainte-Justine, Montreal, Quebec, Canada
- McGill Montreal Children's Hospital, Montreal, Quebec, Canada
- Université Laval, Québec, Quebec, Canada
Collaborators
Canadian Institutes of Health Research (CIHR) · Stem Cell Network
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07058025 on ClinicalTrials.govOther trials for Bronchopulmonary dysplasia
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07561125Effects of IVIG for BPD in Preterm Infant Born at 28 Weeks and BelowInternational Peace Maternity and Child Health Hospital
- RECRUITINGNANCT06373289Pulmonary Hypertension and Oxygen Saturation Targeting in Preterm InfantsUniversity of Alabama at Birmingham
- RECRUITINGNCT07109791National Surveillance and Prevention of Neonatal VAPUniversity of Alberta
- RECRUITINGPHASE2NCT06915441Lipid Infusions to Optimize Nutrition TrialThe University of Texas Health Science Center, Houston
- RECRUITINGPHASE1, PHASE2NCT07101640PK, Safety and Preliminary Efficacy Study of Montelukast in Critically Ill Infants With Developing Bronchopulmonary DysplasiaDuke University
- RECRUITINGNCT07273643Characterization of Extracellular Vesicles From the Cord Blood of Extremely Preterm New Borns and Their Correlation With Severe Morbidity and MortalityUniversity Hospital, Montpellier
- RECRUITINGEARLY PHASE1NCT07120971Metformin for Premature Infants With Bronchopulmonary DysplasiaMedical College of Wisconsin
- RECRUITINGPHASE1NCT06589245Inhaled Ciclesonide Study in Preterm InfantsVenkatesh Sampath